221 related articles for article (PubMed ID: 9521645)
1. Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen.
Chang Y; Mochalkin I; McCance SG; Cheng B; Tulinsky A; Castellino FJ
Biochemistry; 1998 Mar; 37(10):3258-71. PubMed ID: 9521645
[TBL] [Abstract][Full Text] [Related]
2. Ligand preferences of kringle 2 and homologous domains of human plasminogen: canvassing weak, intermediate, and high-affinity binding sites by 1H-NMR.
Marti DN; Hu CK; An SS; von Haller P; Schaller J; Llinás M
Biochemistry; 1997 Sep; 36(39):11591-604. PubMed ID: 9305949
[TBL] [Abstract][Full Text] [Related]
3. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein.
Rios-Steiner JL; Schenone M; Mochalkin I; Tulinsky A; Castellino FJ
J Mol Biol; 2001 May; 308(4):705-19. PubMed ID: 11350170
[TBL] [Abstract][Full Text] [Related]
4. Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid.
Mathews II; Vanderhoff-Hanaver P; Castellino FJ; Tulinsky A
Biochemistry; 1996 Feb; 35(8):2567-76. PubMed ID: 8611560
[TBL] [Abstract][Full Text] [Related]
5. The construction and expression of chimeric urokinase-type plasminogen activator genes containing kringle domains of human plasminogen.
Boutaud A; Castellino FJ
Arch Biochem Biophys; 1993 Jun; 303(2):222-30. PubMed ID: 8512311
[TBL] [Abstract][Full Text] [Related]
6. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
[TBL] [Abstract][Full Text] [Related]
7. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties.
Chang Y; Zajicek J; Castellino FJ
Biochemistry; 1997 Jun; 36(25):7652-63. PubMed ID: 9201906
[TBL] [Abstract][Full Text] [Related]
8. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of apolipoprotein(a) kringle IV37 free and complexed with 6-aminohexanoic acid and with p-aminomethylbenzoic acid: existence of novel and expected binding modes.
Mikol V; LoGrasso PV; Boettcher BR
J Mol Biol; 1996 Mar; 256(4):751-61. PubMed ID: 8642595
[TBL] [Abstract][Full Text] [Related]
10. Functional independence of the kringle 4 and kringle 5 regions of human plasminogen.
Menhart N; McCance SG; Sehl LC; Castellino FJ
Biochemistry; 1993 Aug; 32(34):8799-806. PubMed ID: 8395882
[TBL] [Abstract][Full Text] [Related]
11. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape.
Christen MT; Frank P; Schaller J; Llinás M
Biochemistry; 2010 Aug; 49(33):7131-50. PubMed ID: 20617841
[TBL] [Abstract][Full Text] [Related]
12. Structure of the lysine-fibrin binding subsite of human plasminogen kringle 4.
Mulichak AM; Tulinsky A
Blood Coagul Fibrinolysis; 1990 Dec; 1(6):673-9. PubMed ID: 1966798
[TBL] [Abstract][Full Text] [Related]
13. Solution structure and functional characterization of human plasminogen kringle 5.
Battistel MD; Grishaev A; An SS; Castellino FJ; Llinás M
Biochemistry; 2009 Nov; 48(43):10208-19. PubMed ID: 19821587
[TBL] [Abstract][Full Text] [Related]
14. Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids.
Hoover GJ; Menhart N; Martin A; Warder S; Castellino FJ
Biochemistry; 1993 Oct; 32(41):10936-43. PubMed ID: 8218159
[TBL] [Abstract][Full Text] [Related]
15. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of ligand binding and denaturation for His64 mutants of tissue plasminogen activator kringle-2 domain.
Kelley RF; DeVos AM; Cleary S
Proteins; 1991; 11(1):35-44. PubMed ID: 1961700
[TBL] [Abstract][Full Text] [Related]
17. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
18. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
20. Kringle-kringle interactions in multimer kringle structures.
Padmanabhan K; Wu TP; Ravichandran KG; Tulinsky A
Protein Sci; 1994 Jun; 3(6):898-910. PubMed ID: 8069221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
